Literature DB >> 11624159

Juhn A. Wada and the sodium amytal test in the first (and last?) 50 years.

W van Emde Boas.   

Abstract

Fifty years ago Juhn A. Wada developed the intracarotid amobarbital procedure (IAP), a test in which first one and then the other cerebral hemisphere is temporarily anaesthetised through direct intracarotid application of sodium amytal. The IAP was devised initially as a method to allow unilateral electroconvulsive shock therapy for psychosis. The method subsequently proved its value for the lateralisation of language and, following adaption of the test protocol, for the assessment of memory functions. Thus the IAP became the standard test in the presurgical evaluation for resective surgical treatment of medically intractable epilepsy. This paper will briefly review the history of the IAP, the controversies concerning its current applications and its expected eventual replacement by less invasive and more easily repeatable methods, notably functional magnetic resonance imaging.

Entities:  

Mesh:

Year:  1999        PMID: 11624159     DOI: 10.1076/jhin.8.3.286.1819

Source DB:  PubMed          Journal:  J Hist Neurosci        ISSN: 0964-704X            Impact factor:   0.529


  3 in total

Review 1.  Mapping cognitive function.

Authors:  Steven M Stufflebeam; Bruce R Rosen
Journal:  Neuroimaging Clin N Am       Date:  2007-11       Impact factor: 2.264

2.  Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy.

Authors:  Marta Szantroch; Aleksandra Bala; Andrzej Rysz; Jarosław Żyłkowski; Andrzej Marchel
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

3.  Wada test results contribute to the prediction of change in verbal learning and verbal memory function after temporal lobe epilepsy surgery.

Authors:  Nadine Conradi; Friederike Rosenberg; Susanne Knake; Louise Biermann; Anja Haag; Iris Gorny; Anke Hermsen; Viola von Podewils; Marion Behrens; Marianna Gurschi; Richard du Mesnil de Rochemont; Katja Menzler; Sebastian Bauer; Susanne Schubert-Bast; Christopher Nimsky; Jürgen Konczalla; Felix Rosenow; Adam Strzelczyk
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.